This inventor holds 3 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignee: Rutgers, The State University of New Jersey. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: Innovations of Juan-Carlos Collantes
Introduction
Juan-Carlos Collantes is a prominent inventor based in Princeton, NJ. He has made significant contributions to the field of gene editing, holding a total of three patents. His work focuses on developing advanced systems for targeted gene editing, which have the potential to revolutionize genetic research and therapy.
Latest Patents
Juan-Carlos Collantes' latest patents include a "Nuclease-independent targeted gene editing platform and uses thereof." This invention discloses a system for targeted gene editing and its related applications. Another notable patent is the "Targeted gene editing platform independent of DNA double strand break and uses thereof," which also presents systems for targeted gene editing and their various uses.
Career Highlights
Collantes is affiliated with Rutgers, the State University of New Jersey, where he continues to advance his research in gene editing technologies. His innovative approaches have garnered attention in the scientific community, contributing to the ongoing evolution of genetic engineering.
Collaborations
One of his notable collaborators is Shengkan Jin, with whom he has worked on various projects related to gene editing.
Conclusion
Juan-Carlos Collantes is a key figure in the field of gene editing, with a focus on developing innovative technologies that enhance targeted gene editing. His contributions are paving the way for future advancements in genetic research and therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile